[Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE